Gene expression of O-GlcNAc cycling enzymes in human breast cancers

Zachara NE, Hart GW (2006) Cell signaling, the essential role of O-GlcNAc. Biochim Biophys Acta 1761:599–617

Hart GW, Housley MP, Slawson C (2007) Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017–1022

Özcan S, Andrali SS, Cantrell JEL (2010) Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799:353–364

Hu P, Shimoji S, Hart GW (2010) Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation. FEBS Lett 584:2526–2538

Butkinaree C, Park K, Hart GW (2010) O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 1800:96–106

Zeidan Q, Hart GW (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123:13–22

Heckel D, Comtesse N, Brass N, Blin N, Zang KD, Meese E (1998) Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum Mol Genet 7:1859–1872

Comtesse N, Maldener E, Meese E (2001) Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem Biophys Res Commun 283:634–640

Lazarus BD, Love DC, Hanover JA (2009) O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol 41:2134–2146

Hanover JA, Krause MW, Love DC (2010) The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 1800:80–95

Slawson C, Copeland RJ, Hart GW (2010) O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci 35:547–555

Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW (2005) Perturbations in O-linked-beta-N-acetylglucosamine protein modification causes in severe defects in mitotic progression and cytokinesis. J Biol Chem 280:32944–32956

Kamemura K, Hayes BK, Comer FI, Hart GW (2002) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of Thr58, a known mutational hot spot of c-myc in lymphomas, is regulated by mitogens. J Biol Chem 277:19229–19235

Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, Cho JW (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8:1074–1083

Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ (2010) Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29:2831–2842

Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X, Cong Q, Yu W (2011) O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 1812:514–519

Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, Yang J, Han F, Liu X, Yu W (2010) GlcNAcylation plays an essentials role in breast cancer metastasis. Cancer Res 70:6344–6351

Shi Y, Tomic J, Wen F, Shaha S, Bahlo A, Harrison R, Dennis JW, Williams R, Gross BJ, Walker S, Zuccolo J, Deans JP, Hart GW, Spaner DE (2010) Aberrant O-GlcNAcylation characterizes chronic lymphatic leukemia. Leukemia 12:1588–1598

Dahl E, Sadr-Nabavi A, Klopocki E et al (2005) Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 205:21–28

Slawson C, Pidala I, Potter R (2001) Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 1537:147–157